Tissue microarrays: bridging the gap between research and the clinic

被引:50
作者
Braunschweig, T
Chung, JY
Hewitt, SM [1 ]
机构
[1] NCI, Tissue Array Res Program, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
[2] Inje Univ, Coll Med, PharmacoGenom Res Ctr, Pusan, South Korea
[3] Inje Univ, Coll Med, Mol Cell Physiol Res Grp, Pusan 614735, South Korea
关键词
cell line; clinical trials; high throughput; histology methodologies; pathology; proteomics; tissue microarray; TMA; translational medicine; xenograft;
D O I
10.1586/14789450.2.3.325
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Tissue microarrays are a high-throughput method for the Investigation of biomarkers in multiple tissue specimens at once. This technique allows for the analysis of up to 500 tissue samples in a single experiment using immunohistochemistry and in situ hybridization. Recently, cell lines and xenografts have been reduced to a tissue microarray format and are being applied to preclinical drug development. In clinical research, tissue microarrays are applied at multiple levels: comprehensive analysis of samples in the context of a clinical trial or across a population. Tissue microarrays play a central role in translational research, facilitating the discovery of molecules that have potential roles in the diagnosis, prognosis and prediction of response to therapy.
引用
收藏
页码:325 / 336
页数:12
相关论文
共 81 条
[81]  
Zimmerman D, 2003, J HISTOTECHNOL, V26, P181